July 30, 2010
Alan R. Goodman
Alan Goodman
Practice Areas Airplane Accidents Bad Drugs Bad Foods Boating Accidents Car Accidents Cerebral Palsy Construction Accidents Dangerous Products Dog Bites DUI / DRAM Medical Malpractice Medical Spas Motorcycle Accidents Nursing Home Abuse Personal Injury Law Pharmacy, Pharmacist, Filling Prescriptions Premises Liability Railroad Accidents Slip & Fall Accidents Social Security Law Spinal Cord Injury Traumatic Brain Injury Unintentional Poisoning Deaths from Medication Workers' Compensation Wrongful Death
Product Recalls and LitigationDrug Recalls and Litigation
Blog With Us
Phone 413-736-1616Quick Connect
FeaturesAmerican Association for JusticeNews You Can UseContact CongressOnline JuryLegal DictionaryInstructions for Injury ClientsHome Safety TipsFree Case Evaluation
More Content Useful Links Resources Food & Wine

Mass Tort Drug Litigation

Pharmaceutical companies manufacture and market hundreds of new drugs each year. Each product is regulated and approved by the Food and Drug Administration before it reaches the consumer, and every year over 200,000 people die from using these drugs. It is estimated that more than 50% of all the drugs marketed to the American consumer have deleterious effects, in spite of testing and FDA regulation.

Of all the recent examples of harmful drugs, most were withdrawn from sale within 12 months of release. Some drugs were still marketed by drug companies even after evidence of serious side effects or death had been noted. By law, drug manufacturers are strictly liable for injuries if the product they sell is defective or unreasonably dangerous. This can happen in several ways.

In all these cases, the manufacturer is liable and can be sued for damages even if they were unaware of the danger. It does not matter how carefully the product was produced or labeled.

Many drug products have caused such widespread injury that class action suits or mass torts have been filed against them. Some of these drugs include: Baycol, Phen-fen, Rezulin, Propulsid, and PPA.

Of additional concern are the dietary supplements which are becoming increasingly popular. The FDA requires that manufacturers assure that such supplements are safe before selling them, but there are no testing or approval requirements.

If you or a loved one is in need of legal assistance, call The Law Offices of Alan R. Goodman at 1-413-736-1616 or submit an online questionnaire. The initial consultation is free of charge, and if we agree to handle your case, we will work on a contingency fee basis, which means we get paid for our services only if there is a monetary recovery of funds. In many cases, a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. Please call right away to ensure that you do not waive your right to possible compensation.


More Information

Accutane Advair Arava Avandia Baycol BextraCardura Celebrex Comfrey Crestor Duract Duragesic Pain Patch Ephedra Lamisil / Sporanox Meridia Neurontin Oxycontin Paxil Fen-Phen Fen-Phen Heart Disease Pondimin Advanced Bionics
Gadolinium
Heparin
Hydroxycut
Ortho Evra
ReNu MoistureLoc
Oral Sodium Phosphates
Prempro / PremellePropulsid Prozac PPA PPH Raplon Raxar Redux Redux / Pondimin Settlement Agreement Remicade Rezulin Ritalin Serentil Serzone Stadol Trovan Viagra Vioxx Zyban Zyprexa Shoulder Pain Pump Stryker Hip Implants
Yaz / Yasmin / Ocella Zicam
Zimmer Durom
Digitek

Resources

Antibiotics linked to liver damage
Drug-Induced Liver Injury Network
The National Institute of Diabetes and Digestive and Kidney Disease

Disclainer: Attorney Goodman is licensed to practice law in Massachusetts only but does appear in Federal Courts throughout the country on motion and through local counsel; most cases outside Massachusetts are referred to affiliates; past results is no guarantee of future results; legal information offered here is for informational purposes only and does not constitute formal legal advice; submission of a client inquiry is confidential but does not give rise to an attorney client relationship unless a formal fee agreement is signed by both parties.